Sequential Revenue Growth
15% growth on a quarter-over-quarter basis in Q2, driven by strong execution in a challenging environment with mid-teens growth in both the U.S. and international markets.
Cash System Sales Increase
Cash system sales in the U.S. represented 65% of total U.S. system sales in Q2 compared to 58% last year, indicating a strategic shift towards higher quality cash revenues.
Strategic Sale of Venous Hair Business
Definitive agreement to sell the Venous Hair business to Meta Health Group for $20 million, expected to improve revenue growth, lower operating expenses, and enhance cash flow.
Debt Reduction and Financing Progress
Significant progress in improving the balance sheet with cash and cash equivalents of $4.9 million and total debt obligations reduced to approximately $34.3 million.